Literature DB >> 188315

Cyclic AMP and gastric secretion: the illusive second messenger.

E D Jacobson, W J Thompson.   

Abstract

We have surveyed the literature which bears upon the contention that accumulation of intracellular cyclic AMP is a necessary intermediate event between secretagogue and secretion of acid by the stomach. In our view, the evidence in favor of this hypothesis is wanting for these three reasons: (i) the evidence does not fit with better established information about regulation of gastric secretion and about hormonal actions on the cyclic AMP system; (ii) technological problems involved in the biological preparations employed and in the assay procedures used make the evidence nearly uninterpretable; and (iii) there exists a body of contradictory evidence at least as convincing as that which favors the thesis. These three arguments against acceptance of the theory are not definitive and are not intended to dissuade investigators interested in gastric mucosal metabolism from their quest. And, although we are not at this time adherents of the preceding hypothesis, we are also not unmindful of its basic appeal, which has attracted numerous scientists into a study of the metabolic correlates of gastric acid secretion. Unfortunately the general appeal of the second messenger hypothesis is such as to make it almost a paradigm of gastric secretory physiology in the seventies, in Kuhn's sense of that word (118). The disadvantages of paradigms are that they tend to obscure negative evidence among their adherents, and they arouse controversies more marked by heat than by light.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 188315

Source DB:  PubMed          Journal:  Adv Cyclic Nucleotide Res        ISSN: 0084-5930


  15 in total

1.  Effect of the phosphodiesterase inhibitor 4-(3-cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711) on gastric secretion and gastric mucosal cyclic AMP.

Authors:  J Puurunen; C Lücke; U Schwabe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-08       Impact factor: 3.000

2.  Studies on the mechanism of the inhibitory effect of ethanol on the gastric acid output in the rat.

Authors:  J Puurunen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-05       Impact factor: 3.000

Review 3.  Gastrointestinal cytoprotection by prostaglandins.

Authors:  T A Miller; E D Jacobson
Journal:  Gut       Date:  1979-01       Impact factor: 23.059

4.  Regulation by histamine of cAMP-dependent protein kinase in guinea-pig stomach.

Authors:  O Holian; C T Bombeck; L M Nyhus
Journal:  Agents Actions       Date:  1984-02

5.  Effect of histamine and stress on the gastric mucosal Ca2+ content during the development of gastric ulcers.

Authors:  L L Grechishkin; K Riethling; U Zelck; U Karnstedt
Journal:  Agents Actions       Date:  1979-12

6.  Cyclic nucleotides and the regulation of canine gastric acid secretion.

Authors:  D Thurston; P Tao; D E Wilson
Journal:  Dig Dis Sci       Date:  1979-04       Impact factor: 3.199

7.  Effects of nonsteroidal anti-inflammatory drugs on rat gastric mucosal phosphodiesterase activity.

Authors:  J Silvola; M Kangasaho; O Tokola; H Vapaatalo
Journal:  Agents Actions       Date:  1982-10

8.  TVX 2706--a new phosphodiesterase inhibitor with antiinflammatory action. Biochemical characterization.

Authors:  T Glaser; J Traber
Journal:  Agents Actions       Date:  1984-10

9.  Human gastric mucosal adenylate cyclase: activation by histamine-H2-receptor stimulation and inhibition by cimetidine in vitro and in peptic ulcer patients.

Authors:  H J Ruoff; M Becker; B Painz; M Rack; K F Sewing; H Malchow
Journal:  Eur J Clin Pharmacol       Date:  1979-04-17       Impact factor: 2.953

10.  Specific inhibition by prostaglandins E2 and I2 of histamine-stimulated [14C]aminopyrine accumulation and cyclic adenosine monophosphate generation by isolated canine parietal cells.

Authors:  A H Soll
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.